These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8985276)

  • 1. Hepatic amyloidosis: clinical appraisal in 77 patients.
    Gertz MA; Kyle RA
    Hepatology; 1997 Jan; 25(1):118-21. PubMed ID: 8985276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The premortem recognition of systemic senile amyloidosis with cardiac involvement.
    Kyle RA; Spittell PC; Gertz MA; Li CY; Edwards WD; Olson LJ; Thibodeau SN
    Am J Med; 1996 Oct; 101(4):395-400. PubMed ID: 8873510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients.
    Park MA; Mueller PS; Kyle RA; Larson DR; Plevak MF; Gertz MA
    Medicine (Baltimore); 2003 Sep; 82(5):291-8. PubMed ID: 14530778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloidosis and cardiac involvement.
    Cacoub P; Axler O; De Zuttere D; Hausfater P; Amoura Z; Walter S; Wechsler B; Godeau P; Piette JC
    Ann Med Interne (Paris); 2000 Dec; 151(8):611-7. PubMed ID: 11173703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.
    Gertz MA; Leung N; Lacy MQ; Dispenzieri A; Zeldenrust SR; Hayman SR; Buadi FK; Dingli D; Greipp PR; Kumar SK; Lust JA; Rajkumar SV; Russell SJ; Witzig TE
    Nephrol Dial Transplant; 2009 Oct; 24(10):3132-7. PubMed ID: 19403931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey.
    Hosenpud JD; DeMarco T; Frazier OH; Griffith BP; Uretsky BF; Menkis AH; O'Connell JB; Olivari MT; Valantine HA
    Circulation; 1991 Nov; 84(5 Suppl):III338-43. PubMed ID: 1934428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function at the time of renal biopsy as a predictor of prognosis in patients with primary AL-type amyloidosis.
    Osawa Y; Kawamura K; Kondo D; Imai N; Ueno M; Nishi S; Iino N; Okada M; Suzuki Y; Hoshino S; Yamazaki H; Kishimoto H; Shimada H; Yamagishi T; Ishiyama T; Narita I; Gejyo F
    Clin Exp Nephrol; 2004 Jun; 8(2):127-33. PubMed ID: 15235929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloidosis with IgM monoclonal gammopathies.
    Gertz MA; Kyle RA
    Semin Oncol; 2003 Apr; 30(2):325-8. PubMed ID: 12720162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis.
    Uda H; Yokota A; Kobayashi K; Miyake T; Fushimi H; Maeda A; Saiki O
    J Rheumatol; 2006 Aug; 33(8):1482-7. PubMed ID: 16881107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis.
    Bochtler T; Hegenbart U; Heiss C; Benner A; Cremer F; Volkmann M; Ludwig J; Perz JB; Ho AD; Goldschmidt H; Schonland SO
    Haematologica; 2008 Mar; 93(3):459-62. PubMed ID: 18287137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis.
    Bergesio F; Ciciani AM; Santostefano M; Brugnano R; Manganaro M; Palladini G; Di Palma AM; Gallo M; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2007 Jun; 22(6):1608-18. PubMed ID: 17395661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Globular hepatic amyloid: an early stage in the pathway of amyloid formation: a study of 20 new cases.
    Makhlouf HR; Goodman ZD
    Am J Surg Pathol; 2007 Oct; 31(10):1615-21. PubMed ID: 17895765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and origin of amyloid in kidney biopsies.
    von Hutten H; Mihatsch M; Lobeck H; Rudolph B; Eriksson M; Röcken C
    Am J Surg Pathol; 2009 Aug; 33(8):1198-205. PubMed ID: 19561448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.
    Palladini G; Campana C; Klersy C; Balduini A; Vadacca G; Perfetti V; Perlini S; Obici L; Ascari E; d'Eril GM; Moratti R; Merlini G
    Circulation; 2003 May; 107(19):2440-5. PubMed ID: 12719281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
    Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
    Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.
    Nakamura T; Higashi S; Tomoda K; Tsukano M; Baba S; Shono M
    Rheumatology (Oxford); 2006 Jan; 45(1):43-9. PubMed ID: 16219644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival.
    Prokaeva T; Spencer B; Kaut M; Ozonoff A; Doros G; Connors LH; Skinner M; Seldin DC
    Arthritis Rheum; 2007 Nov; 56(11):3858-68. PubMed ID: 17968927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.